University of Cincinnati Cancer Center
Obstetrics and Gynecology
Dr. Thomas Herzog is the Deputy Director of the University of Cincinnati Cancer Center. He is also Vice-Chair of Quality and Safety for Obstetrics and Gynecology, University of Cincinnati College of Medicine. From 2004 to 2014 he was the Director of Gynecologic Oncology and the Physicians & Surgeons Endowed Professor of Clinical Gynecology and Obstetrics at Columbia University. He also was the Fellowship Director in Gynecologic Oncology for Columbia & Cornell Universities and New York Presbyterian Hospitals. Prior to 2004, he was as an Associate Professor, and the Director of the Fellowship Training Program at Washington University in St. Louis.
He is Secretary Treasurer of the GOG-Foundation and is Associate-Director of GOG Partners as well as President-elect of the GOG-Foundation. Dr. Herzog has authored/co-authored over 315 peer-reviewed articles and lectures extensively nationally and internationally. He serves or has served on the editorial boards of Gynecologic Oncology, Obstetrics and Gynecology International, Hematology Oncology Times, and others. He served as Editor–in chief of Women’s Oncology Review and Gynecologic Oncology Research to Practice. Dr. Herzog has served on the board of directors or leadership council of the Society of Gynecologic Oncology, the Foundation for Women’s Cancer, Board of Governors for the American College of Surgeons, American Board of Obstetrics and Gynecology, and the International Gynecologic Cancer Society.
Moderator of 2 Sessions
Session Type
Master Session
Date
09/30/2022
Session Time
04:00 PM - 06:25 PM
Room
Hall 501
Chair(s)
Session Description
This session is dedicated to innovations in ovarian cancer biology, surgery and treatment. Speakers in this session will cover the role of “biology” in clinical outcomes and potential for surgical decision making, timing and new approaches. With the growing interest in intraoperative treatments, a critical appraisal of HIPEC will be performed. The second part will discuss current and emerging systemic therapies in the first-line setting and how the ongoing trials may change clinical practice. Next, several “hot topics” in ovarian cancer will be presented, including the mechanisms of resistance to PARP inhibitors, front-line maintenance therapy as part of standard-of-care (SOC) for at least 50% of women with ovarian cancer and the new and very promising developmental therapies. To close this session dedicated to ovarian cancer, a debate on the role of surgery for relapsed disease from the US and European perspectives will be debated.
Session Type
Industry Symposia
Date
10/01/2022
Session Time
12:35 PM - 02:05 PM
Room
Hall 406
Session Description
Molecular Profiling in Gynecologic Cancers: Now and Into the Future - Industry Symposium by Caris Life Sciences
Session Description:
Join Shannon N. Westin, M.D., M.P.H., F.A.C.O.G., Jubilee Brown M.D., and Matthew A. Powell, M.D. as they discuss the importance of molecular profiling for clinical trial inclusion, rare gynecologic tumors, and endometrial cancer.
Presenter of 10 Presentations
Panel Discussion
Session Type
Plenary Session
Date
09/30/2022
Session Time
02:45 PM - 03:55 PM
Room
Hall 501
Presenter
- Robert L Coleman (United States of America)
- Paul A. DiSilvestro (United States of America)
- Antonio Gonzalez-Martin (Spain)
- Thomas J. Herzog (United States of America)
- Mansoor R. Mirza (Denmark)
- Bradley J. Monk (United States of America)
- Kathleen N. Moore (United States of America)
- Amit Oza (Canada)
- Isabelle L. Ray-Coquard (France)
- Brian M. Slomovitz (United States of America)
- Jonathan A. Ledermann (United Kingdom)
Lecture Time
03:13 PM - 03:51 PM
Q&A from the audience
Session Name
Session Type
Industry Symposia
Date
09/29/2022
Session Time
11:55 AM - 01:25 PM
Room
Hall 501
Presenter
Lecture Time
01:10 PM - 01:23 PM
Debate: Surgery in Relapsed Ovarian Cancer - Con
Session Type
Regional/Partner Session
Date
10/01/2022
Session Time
09:15 AM - 10:00 AM
Room
Hall 406
Lecture Time
09:48 AM - 09:58 AM
Introduction
Session Name
Session Type
Industry Symposia
Date
10/01/2022
Session Time
12:35 PM - 02:05 PM
Room
Hall 406
Lecture Time
12:35 PM - 12:41 PM
• Is it ready for primetime? Addressing the knowledge gaps in HIPEC data
Session Name
Session Type
Master Session
Date
09/30/2022
Session Time
04:00 PM - 06:25 PM
Room
Hall 501
Lecture Time
05:33 PM - 05:48 PM
What have we learned?
Session Name
Session Type
Industry Symposia
Date
09/29/2022
Session Time
11:55 AM - 01:25 PM
Room
Hall 501
Presenter
Lecture Time
12:10 PM - 12:30 PM
DEBATE 2: SECONDARY CYTOREDUCTION (27 min) – moderated by Thomas Herzog
Session Name
Session Type
Master Session
Date
09/30/2022
Session Time
04:00 PM - 06:25 PM
Room
Hall 501
Lecture Time
05:48 PM - 05:48 PM
Applying our knowledge
Session Name
Session Type
Industry Symposia
Date
09/29/2022
Session Time
11:55 AM - 01:25 PM
Room
Hall 501
Presenter
Lecture Time
12:30 PM - 12:50 PM
Closing Comments
Session Name
Session Type
Master Session
Date
09/30/2022
Session Time
04:00 PM - 06:25 PM
Room
Hall 501
Lecture Time
06:14 PM - 06:17 PM
Lessons for the future
Session Name
Session Type
Industry Symposia
Date
09/29/2022
Session Time
11:55 AM - 01:25 PM
Room
Hall 501
Presenter
Lecture Time
12:50 PM - 01:10 PM